A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
Clinical trial NCT05247619 · UNKNOWN
Trial details
- NCT number
- NCT05247619
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-30
- Primary completion
- 2024-08-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.